Navigation Links
Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
Date:9/17/2009

he indication of weight management. It contains two alternate efficacy benchmarks. The guidance provides that, in general, a product can be considered effective for weight management if after one year of treatment either of the following occurs: (1) the difference in mean weight loss between the active-product and placebo-treated groups is at least 5% and the difference is statistically significant, or (2) the proportion of subjects who lose greater than or equal to 5% of baseline body weight in the active-product group is at least 35%, is approximately double the proportion in the placebo-treated group, and the difference between groups is statistically significant.

About Lorcaserin

Lorcaserin is a novel single agent that represents the first in a new class of selective serotonin 2C receptor agonists. The serotonin 2C receptor is expressed in the brain, including the hypothalamus, an area involved in the control of appetite and metabolism. Stimulation of this receptor is strongly associated with feeding behavior and satiety. Arena has patents that cover lorcaserin in the US and other jurisdictions, which in most cases are capable of continuing into 2023 without taking into account any patent term extensions or other exclusivity Arena might obtain.

About Weight Management

The National Institutes of Health reported in 2007 that about 65% of US adults are overweight or obese. A 2009 publication in Health Affairs estimated the annual medical burden of obesity in the US to be $147 billion in 2008. Studies have shown that weight loss of 5% to 10% is medically significant and results in meaningful improvements in cardiovascular risk factors and a significant reduction in the incidence of type 2 diabetes in patients with glucose intolerance.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on d
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)...  The U.S. Food and Drug Administration,s (FDA) ... biosimilar product approved in the United ... the contract manufacturing organization (CMO) industry, according to ... to the production of small-molecular drugs and lacks ... healthcare market research publisher,s report, Biopharmaceutical and ...
(Date:5/22/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/28m7nx/guide_to_prepare ) has announced ... Application Dossiers for Oversea Medical device registration and ... to their offering. The Chinese medical ... the most growth potentiality, which is attracting more ... to penetrate such market. It is estimated that ...
(Date:5/22/2015)... , May 22, 2015 ... clinical research unit with a worldwide reputation for ... its frequent publications in peer reviewed medical journals. ... stakeholders and regulators in discussions about rules for ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical ...
Breaking Medicine Technology:Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3
... PALM BEACH, Fla., Jan. 27, 2011 The Mobile Dog ... an afternoon of free heart health examinations at Dreher Dog ... certified veterinary cardiologists will perform on-site heart screenings in a ... heart disease. (Photo:   http://photos.prnewswire.com/prnh/20110127/CG37759 ) ...
... 2011 JHP Pharmaceuticals, a leading provider ... today that it has entered into a multi-year contract ... veterinary pharmaceutical products. JHP will be responsible for manufacturing ... Jean Hoffman, CEO and founder of Putney said, "We ...
Cached Medicine Technology:Vets to Provide Free Dog Heart Checks in West Palm Beach 2Vets to Provide Free Dog Heart Checks in West Palm Beach 3JHP Pharmaceuticals and Putney Inc. Announce Multi-Year Contract Manufacturing Agreement 2
(Date:5/22/2015)... Power Systems is proud to announce the sponsorship of Elite ... in his second year of racing in the professional division ... Department in Missoula, MT. He entered the triathlon scene in ... he has had 15 1st Place finishes. In his first ... all seven of his 2014 races, including two 2nd Place ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 According to ... hub for drug related death, totaling almost 2,500 confirmed drug ... reported by state officials, totals 2,489 deaths stemming from legal ... out, Pennsylvania loses seven people every day to fatal overdoses ... been singled out as one of the most rife with ...
(Date:5/22/2015)... May 22, 2015 Medivo, Inc., a leader ... Rates and Genotype Results in ‘Baby Boomers’ Screened for HCV ... Nationwide Lab Test Database” at Digestive Disease Week, May 16-19, ... Affairs and Analytics team members Carol Smyth, MB; Jason Bhan, ... Parker, MSI, along with Nancy Reau, MD from the University ...
(Date:5/22/2015)... FL (PRWEB) May 22, 2015 Wimbledon ... provides vascular, electrocardiogram (EKG), echocardiogram and NCV testing ... Sempier, a highly respected All American National athlete, to ... athlete, I find the high level of testing and ... the athlete and their athletic trainers, this way they ...
(Date:5/22/2015)... In an effort to support the athletes of ... donate $5 dollars for every maintenance call, and $25 ... system. Customers have their needs serviced, and donations contributed ... the Special Olympics receives money. Hence the name Everybody ... million athletes, and boasts a myriad of events. This ...
Breaking Medicine News(10 mins):Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
... Pack Your Bag(TM) Events Bring Educational Outreach to Senior ... Older Americans Month ATLANTA, May 12 Eight ... chronic health problem, such as high blood pressure or ... Part D participants take an average of eight or ...
... and health care expert, Pamela D. Wilson of The ... program on 630 KHOW Denver . The ... adult children to talk about aging and caregiving with their parents. ... crises and have no idea how to navigate not only health ...
... NEW BRUNSWICK, N.J., May 12 Johnson & Johnson (NYSE: ... financial analysts at noon (Eastern Time) on Tuesday, May 19, ... the pivotal European trial of the NEVO(TM) Sirolimus-eluting Coronary Stent. ... unique reservoir (RES) technology . Results from ...
... May 12 NeuroScience, Inc. has launched NeuroSLP, ... in the hormones and neurotransmitters that regulate sleep. ... more informed decisions regarding patient care. The NeuroSLP ... healthcare practitioners approach sleep difficulties. The system combines ...
... supplement combined with vitamin D and calcium can significantly ... a new study from a Saint Louis University scientist ... results of our study are very promising. Similar studies ... found. However, calcium and vitamin D deficiencies, which are ...
... are just some of the things that older people living ... life, according to research in the May issue of the ... National University of Ireland (NUI), Galway, spoke to 101 older ... large facilities, well-established and recently built homes and those provided ...
Cached Medicine News:Health News:The National Council on Aging and CVS/pharmacy Educate Georgia Seniors about Medication Management and Ways to Save Money on Prescription Drugs 2Health News:The National Council on Aging and CVS/pharmacy Educate Georgia Seniors about Medication Management and Ways to Save Money on Prescription Drugs 3Health News:The National Council on Aging and CVS/pharmacy Educate Georgia Seniors about Medication Management and Ways to Save Money on Prescription Drugs 4Health News:The Care Navigator Announces Parenting Your Parents Radio 2Health News:New System for Managing Sleep Disorders Aims to Improve Sleep Through Brain Chemistry 2Health News:A stronger backbone: DHEA hormone replacement increases bone density in older women 2Health News:A stronger backbone: DHEA hormone replacement increases bone density in older women 3Health News:Quality of life survey highlights need for holistic approach in elderly residential care 2Health News:Quality of life survey highlights need for holistic approach in elderly residential care 3
The Rio Catheter is designed to simplify your intravascular interventions by removing thrombus and restoring epicardial flow to the procedure....
The Atria 6100 delivers the highest level of clinical performance while incorporating cutting-edge technology to streamline clinic workflow. It offers timely, high-quality, and accurate ECG results c...
... of technology innovation, the new Guidant VASOVIEW® ... on the VASOVIEW® platform. The new VASOVIEW® ... a familiar platform, combining ease of use ... and finesse into a proven system. Discover ...
...
Medicine Products: